Article Details
Retrieved on: 2025-02-21 18:44:43
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a securities class action lawsuit against AstraZeneca for alleged insurance fraud in China, highlighting securities fraud issues and their impact on AstraZeneca’s legal risks, under the framework of the Private Securities Litigation Reform Act.
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here